Retinal Degeneration clinical trials at UCSF

• Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F

  open to eligible people ages 8 years and up

  The overall goal of this project, co-funded by the Foundation Fighting Blindness and the USHER 1F Collaborative is to characterize the natural history of disease progression in patients with PCDH15 mutations in order to accelerate the development of outcome measures for clinical trials.

  San Francisco, California and other locations

Last updated: July 9, 2021